← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2016Last known activity
Sep 17, 2021
Timeline
2010s
- Jun 1, 2012
Syros Pharmaceuticals— Founded
2020s
- Jul 6, 2022
Tyme, Inc— Acquired
Drugs by trial phase (16 distinct, 11 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 10 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (11)
- NCT04996030Study directorPhase 1Sep 17, 2021
- NCT04996030Lead sponsorPhase 1Sep 17, 2021
- NCT04905407Study directorPhase 2Aug 26, 2021
- NCT04905407Lead sponsorPhase 2Aug 26, 2021
- NCT04797780Study directorPhase 3Feb 8, 2021
- NCT04797780Lead sponsorPhase 3Feb 8, 2021
- NCT04247126Lead sponsorPhase 1Jan 23, 2020
- NCT03134638Study directorPhase 1Jun 1, 2017
- NCT03134638Lead sponsorPhase 1Jun 1, 2017
- NCT02807558Lead sponsorPhase 2Aug 1, 2016
- NCT02807558Study directorPhase 2Aug 1, 2016
Details
- Founded
- Watertown, MA, US Jun 1, 2012
- Last known activity
- Sep 17, 2021